Counsyl is proud to announce that our acquisition closed on July 31, 2018 and we have officially combined with Myriad Preventative Care to form Myriad Women’s Health, Inc., a premier women’s health genetic screening and testing company, and new business unit within Myriad.
Together, we remain committed to our common values of improving clinical decisions by putting patients first, putting clinicians in control and putting costs in their place, as well as providing actionable information. Combined, we have provided over two million patient results, and are confident that the new Myriad Women’s Health organization will allow us to better serve our customers.
Unifying the best of both companies will take time, and we are just in the beginning stages. During our transition to a combined company, Counsyl will continue to operate as a trademark of Myriad Women’s Health, Inc.
As our transition progresses, we will periodically communicate updates.
February 25, 2021
I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier
This Sunday, February 28th, is #RareDiseaseDay! To raise awareness and support for the rare disease community, Myriad Women’s Health partnered…Read more about I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier
December 23, 2020
Myriad’s 7 Greatest Hits in 2020
Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access…Read more about Myriad’s 7 Greatest Hits in 2020
December 4, 2020
Knowledge is Power: How PKU Affected the Ahern Family
December 3rd is National PKU Day. PKU, short for phenylketonuria, is an inherited genetic condition in which the body cannot properly…Read more about Knowledge is Power: How PKU Affected the Ahern Family